Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > $1.65-$1.00 in 5 days

<< Previous

Bullboard Posts

Next >>

Comment by Drmrgnon Oct 26, 2023 11:17am

99 Views

Post# 35702161

RE:RE:$1.65-$1.00 in 5 days

The good news is that per the last report, Paul has 111,200 shares, 1,134,728 options and 20,000 warrants. Dawn Svoronos has 323,600 shares, 855 deferred stock units and 105,913 options. Certainly, they want the sp to be as high as possible. They have a lot to lose.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec